arrow
F

Federica Di Nicolantonio

Candiolo Cancer Institute
H指数:63
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

α-ketoglutarate/succinate ratio imbalance impairs thymine DNA glycosylase function and base excision repair process increasing susceptibility to pancreatic cancer

α-酮戊二酸/琥珀酸比率失衡会损害胸腺嘧啶DNA糖基酶功能并影响碱基切除修复过程,从而增加患胰腺癌的易感性。

2026-02-210
OAAI
Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models

顺铂和替莫唑胺联合治疗在实验性癌症模型中触发高突变性和免疫监视。

2025-06-120
OA
A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)

MEK1/2抑制剂比尼美替尼与MET抑制剂克唑替尼在RAS突变型晚期结直肠癌 (汞) 患者中的Ia/b期研究

2025-04-100
OAAI
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection

甲基BEAMing和液滴数字PCR检测MGMT基因启动子甲基化的比较研究

2024-11-050
OA
Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of patients with stage III colon cancer

III期结肠癌患者随访中发现与疾病进展和化疗无关的术后后遗症

2024-10-010
OAAI
Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of stage III colon cancer patients
2024-03-220
PRE
Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer

转录组范围内的基因表达异常值分析指出了结直肠癌的治疗脆弱性

2024-03-112
OA
Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells
2024-02-013
OAAI
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity
2023-05-123
OAAI
A transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer
2023-04-140
PRE